|
|
|
|
|
|
by oaktrout
500 days ago
|
|
|
To emphasize your point, I don't think anyone will notice if someone's alzheimers is 2.3% better. These rating scales like CDR-SB (invented by drug companies or researchers who are funded by drug companies) are very good at making the tiniest improvement sound significant. |
|
|